Rat hepatocytes contain several types of Ca2`-linked receptors, all of which stimulate glycogen breakdown by increasing cytosolic free Ca2" concentration ([Ca2+jc). In vivo desensitization of this Ca2" messenger system was studied in hepatocytes isolated from either pheochromocytoma (PHEO)-harboring and chronically norepinephrine (NE)-infused rats. Homologous desensitization for alpha,-adrenergic receptor-mediated phosphorylase activation developed in the early stage of PHEO rats (3-4 wk after implantation), whereas, in the later stage of tumor development or in the NE-infused rats, phosphorylase responses to all Ca2+-mobilizing stimulations were subsensitive (heterologous desensitization). In the homologous desensitization, the [Ca2"Ic response to alpha,-adrenergic stimulation was selectively reduced. We found, using the phenoxybenzamine inactivation method, that there was a linear relationship between alpha, receptor density and the [Ca2"ic response; consequently, the blunted [Ca2"jc response to alpha,-adrenergic stimulation could not be explained by the 34% downregulation of alpha, receptors seen in these rats.
Introduction
Prolonged exposure of tissues to a variety of hormones or drugs often leads to a blunted response when the tissue is subsequently exposed to the agonist. This phenomenon has been called desensitization, tolerance, or tachyphylaxis. A great deal has been learned over the past decade about the mechanism whereby receptor systems that activate adenylate cyclase may desensitize (1, 2) . For example, uncoupling and downregulation of beta-adrenergic receptors frequently have been found to be associated with the desensitization of adenyl-ate cyclase activation that occurs after prolonged exposure to catecholamines.
Much less is known about desensitization of receptors that function through another important transmembrane signaling system, namely the phosphatidylinositol (PI)' turnover/intracellular Ca2"-mobilizing pathway. Alpha, adrenergic, vasopressin, and angiotensin II receptors are examples of receptors that function through this pathway and cause a rise of intracellular Ca2" ([Ca2+Jc) in a variety of cell types (for review see references 3 and 4) . The increase in the [Ca2+] c that occurs when these receptors are activated may explain many of the physiological effects of these receptors. Several physiological and clinical examples exist that suggest that this signal transduction system also undergoes adaptive changes in the face of continued stimulation (5) (6) (7) (8) (9) .
The liver is a major site of glycogen deposition and breakdown in the regulation of mammalian glucose homeostasis, and the balance between these processes is regulated by a variety of stimulators, including Ca2"-mobilizing hormones. In particular, the regulation of glycogenolysis by Ca2"-linked hormones has been extensively studied in adult male rat liver, in which glycogen phosphorylase, the key enzyme for this process, is mainly regulated by Ca2+-mobilizing hormones. Its biochemical framework is also well established (for review see references 3, 4, 10, and 11); thus, the available experimental evidence indicates that an elevation of [Ca2+ c after the occupation of specific receptors by these Ca2+-mobilizing hormones allosterically activates phosphorylase b kinase ( 12) and results in an increased rate of glycogen breakdown. Several in vitro studies involving an examination of desensitization of glycogen phosphorylase activation by Ca2+-mobilizing hormones (13, 14) have used this model system of isolated rat hepatocytes. However, very little information is available on in vivo desensitization of responses mediated by Ca2+-mobilizing hormones.
In these studies, we have investigated the consequences of prolonged exposure to catecholamines on the activation of hepatic glycogenolysis to Ca2+-mobilizing hormones. High circulating levels of catecholamines were maintained in rats either by transplantable catecholamine-producing tumor pheochromocytoma (PHEO) or by subcutaneously implanted osmotic minipumps. We found that desensitization of hepatic glycogenolysis to Ca2+-mobilizing hormones can occur in in vivo settings. Experiments in hepatocytes isolated from rats chronically exposed to catecholamines revealed multiple mechanisms in the process of desensitization. (17) .
Infusion of norepinephrine (NE) in vivo
To examine whether the altered responsiveness observed in rats with PHEO was attributable solely to elevation of plasma NE or might be related to the presence of the tumor and associated changes in tumorbearing animals, we compared changes using subcutaneously implanted osmotic minipumps to infuse NE. To raise circulating levels of NE in vivo, we implanted osmotic minipumps (Alzet; Alza Corp., Palo Alto, CA) subcutaneously on the backs of male NEDH rats. All rats used were 11-12 wk old and weighed -280-300 g at the time of minipump implantation. 
Analysis ofplasma catecholamine concentrations
To analyze plasma catecholamine concentrations, blood (1 ml) from the inferior vena cava below the level of the renal veins was rapidly collected through an abdominal incision just before starting the liver perfusion. The blood was placed in ice-cold tubes containing 0.1% sodium EDTA as an anticoagulant. After centrifugation at 1,500 g for 10 min, the plasma samples were stored at -80'C until analyzed. Plasma samples were extracted as previously described (18 
Fractional inactivation ofalpha, receptors by phenoxybenzamine
In some experiments to delineate the linkage between alpha,-adrenergic receptor occupation and [Ca2+]c response, we used the phenoxybenzamine inactivation method (7, 23, 24) . In these experiments, to irreversibly inactivate alpha,-adrenergic receptors, phenoxybenzamine was added to the hepatocytes suspension in final concentrations ranging from 10-'6-10-5 M and was incubated for 20 min at 370C. Hepa Glycogen phosphorylase a activity. Glycogen phosphorylase a activity was assayed in liver-cell homogenates prepared as described previously (22). Unless otherwise stated, cell samples were taken for determination of phosphorylase a activity 2 min after hormone additions. Glycogen phosphorylase a activity was measured using a filter disc assay similar to that of Gilboe et al. (25) as modified (26 [Ca2+]c measurement (aequorin). Incorporation of aequorin into isolated hepatocytes was performed by the gravity loading method described by Borle et al. (27) ALM epinephrine, 100 mIU/ml Arg-vasopressin, and 100 nM angiotensin II.
In some experiments, to determine the efficiency of aequorin incorporation, aequorin content was determined in an aequorin assay photometer by measuring the light signal emitted from lysed cells in the presence of a saturating concentration of CaCI2 (28, 29) . The resultant flash of light was recorded as current from the photomultiplier tube and normalized by the cell protein concentration.
[Ca2"]c measurement (quin2). Quin2 loading was achieved essentially as reported by Thomas et al. (30) . The cells were suspended in Hepes buffer containing (in millimolars) NaCl, 120; Hepes, 20; KC1, 5.4; NaHCO3, 4.2; KH2PO4, 1.2; MgSO4, 1.2; CaCl2, 1.0; glucose, 15; and 2.0% (wt/vol) dialyzed BSA at pH 7.4 and maintained under an atmosphere of 02/C02 (95:5%). After 20 min incubation with 100 sM quin2/AM, when maximal accumulation of quin2 had occurred, the cells were washed twice and resuspended, at -3 mg of dry weight/ml in the Hepes buffer described above with the albumin concentration reduced to 0.2%. Quin2 fluorescence measurements were performed in a fluorescence spectrophotometer (model F-3000; Hitachi Ltd., Tokyo, Japan) equipped with a thermostat-controlled cuvette holder and magnetic stirring. Excitation and emission wavelengths were 340 and 490 nm, respectively. Calibration and determination of [Ca2+Jc were done as described by Tsien et al. (31) .
[3H]Prazosin binding. [3H] Prazosin binding experiments were performed on a crude cellular homogenate as previously described (32) . Saturation binding experiments with [3H]prazosin were carried out at a range of 0.5-5 nM.
Protein concentration was determined by the method of Lowry et al. (33) using BSA as standard.
Data analysis. All data for each drug were meaned and the resulting concentration-response curves from each group were analyzed simultaneously using the four-parameter logistic equation (34) . The resulting ED50 and maximal responses (Em..) were analyzed for significant differences using the ALLFIT program. The ALLFIT program is a modification of the DeLean et al. program by Martin H. Teicher, and was obtained from the Biomedical Computing Technology Information Center, Nashville, TN. Data derived from radioligand studies were analyzed by LIGAND, a nonlinear computer-assisted iterative weighed least square curve-fitting procedure (35) .
The experimental data given in the text and figures are the means ±SEM of n experiments as indicated. Differences between means within each experiment were evaluated by analysis ofvariance. Ifanalysis of variance demonstrated a significant difference among means, the t test for unpaired observations was then used to determine which pairs of means were significantly different. The criterion for statistical significance was a P value of < 0.05. In several figures in which no significant difference was obtained either between the younger and older age-matched control NEPH rats or between early and late stage of PHEO rats, these two groups of data were pooled; however, the statistical comparison of responses obtained from either early or late stage of PHEO rats was always made with the corresponding agematched controls.
Results
Effect ofalpha,-adrenergic stimulation on phosphorylase activity and [Ca2+Jc response. Fig. 1 shows the time course for phosphorylase activation and (Ca2+]c signals indicated either by quin2 or aequorin after addition of the alpha1-adrenergic agonist phenylephrine (100 WM) to isolated hepatocytes. Significant phosphorylase activity was observed 5 s after phenylephrine addition, and this approached a maximum value after 15-20 s, which is kept by 3 min (Fig. 1 A) . The time course of [Ca2"Jc sigijals seen in response to phenylephrine differed in aequorin-and quin2-loaded hepatocytes (Fig. 1, B and C). The aequorin signals displayed a more rapid rise in luminescence to a peak followed by a fall to baseline that may represent Glycogen phosphorylase activity was examined in hepatocytes isolated from both stages of PHEO rats. The basal levels of the glycogen phosphorylase activity in cells isolated from PHEO rats were similar to those of age-matched controls. In the presence of 15 mM glucose-l-phosphate, the activities were 0.96±0.21 U/100 mg protein (n = 11) vs. 1.12±0.18 U/ 100 mg protein (n = 9) for the early stage of PHEO rats and age-matched controls; 1.21±0.22 U/ 100 mg protein (n = 10) vs. 1.08±0.24 U/100 mg protein (n = 9) for the late stage of PHEO rats and age-matched controls, respectively. The abilities of alpha-adrenergic agonists, phenylephrine and epinephrine, to activate glycogen phosphorylase in control and both stages ofPHEO rats are presented in Fig. 3 A. In both early and late stages of PHEO rats, the phosphorylase activation was markedly decreased at all concentrations examined compared with that of age-matched controls.
Further experiments were performed to determine if the desensitization in responsiveness to alpha-adrenergic agonists was homologous or heterologous. In this case, homologous desensitization would involve loss of responsiveness only to catecholamines, whereas responsiveness to drugs or hormones causing their action through other receptors would not be impaired (36) . Conversely, heterologous desensitization involves loss in responsiveness to a multiplicity of agonists acting on different receptors (36) . To address this issue, we have examined the phosphorylase activation to the two nonadrenergic hormones, arg-vasopressin and angiotensin II, and the Ca2l ionophore A23187. As shown in Fig. 3 B, in the early-stage PHEO rats, glycogen phosphorylase activation of hepatocytes by these Ca2+-mobilizing stimuli was similar to controls;
whereas, in the late-stage PHEO rats, at all concentrations examined the phosphorylase responses were significantly (P < 0.05) smaller compared with those of controls. Phosphorylase activation by stimulations that cause an increase in cAMP was also shown in Fig. 3 C. In both early and late stages of PHEO rats, phosphorylase activation by Bt2cAMP and forskolin in these rats were not significantly different from those of controls, whereas glucagon-stimulated phosphorylase activation was found to be significantly lower in both stages of PHEO rats than in age-matched control rats.
In an effort to determine the mechanism for the desensitization of hepatic phosphorylase activation to Ca2+-mobilizing hormones in rats harboring PHEO, [Ca2+]c responses in hepatocytes to 100 gM phenylephrine, 10 mIU/ml arg-vasopressin and 10 nM angiotensin II were measured in both early and late stages of PHEO rats. Estimated resting [Ca2+]c values in the presence of 1 mM extracellular Ca2+ for hepatocytes of PHEO rats (aequorin-indicated [Ca2+]c were 181±26 nM, n = 8 and 197±31 nM, n = 7; quin2-indicated [Ca2+]c were 154±22 nM, n = 9 and 186±28 nM, n = 7 for the early and late stage of PHEO rats, respectively) were similar to those of age-matched controls (aequorin-indicated [Ca2+]c were 162±26 nM, n = 6 and 171±33 nM, n = 6; quin2-indicated [Ca2+ c were 197±34 nM, n = 5 and 178+30 nM, n = 5 for the early and late stage of controls, respectively). As shown in Fig. 4 [Ca2+]c changes. Thus, we next examined the possibility that an alteration in alpha1 receptor number or affinity might be associated with the homologous desensitization. Saturation binding experiments performed with hepatocytes membrane preparations from rats with PHEO rats (early stage) showed 34% decrease in total [3H]prazosin binding (100.4±10.8 fmol/ mg protein, n = 5 in control rats vs. 66.2±8.5 fmol/mg protein, n = 5 in PHEO rats, P < 0.05; Fig. 5 , left) without any significant change in the affinity (Kd = 0.14±0.04 nM, n = 5 in control rats vs. Kd = 0.08±0.02 nM, n = 5 in PHEO rats). In addition, the affinity of the alpha1-adrenergic receptors for (-)epinephrine was not significantly different in hepatocyte membrane preparations from PHEO rats when the affinity was determined in competition experiments with [3H]prazosin (Fig. 5, right) . The half-maximal effective concentration (EC50) in controls was 38±9 ,uM, n = 5 vs. 44±12 ,M, n = 5 in PHEO rats. The lack of change in alpha, receptor affinity for the radioligand indicates that circulating catecholamines were not retained on receptors from animals with PHEO; retention of the agonist would be expected to decrease the affinity of the receptor for [3H]prazosin.
Studies in rats infused with NE. Table II summarizes PHEO rats. This extent of increase was detectable by 14 h (the earliest time point tested) and remained at this level for the duration of the infusion (data not shown). Corresponding to the increase of NE, the body weight progressively decreased over the time of the infusion. Hepatic phosphorylase was examined on 1-2, and 4-7 d of NE infusion. The basal level of the glycogen phosphorylase activity was slightly decreased in hepatocytes isolated from NE-infused rats. The activities were 0.97±0.20 U/100 mg protein (n = 1 1) for control, 0.68±0.18 (n = 8) and 0.78±0.21 (n = 1 1) U/100 mg protein for 1-2 d and 4-7 d of NE-infused rats, respectively. The abilities of Ca2"-mobilizing hormones and cAMP-elevating agents to activate glycogen phosphorylase in control and NE-infused rats are presented in Fig. 6 . In both groups of NE-infused rats, the phosphorylase activation to all Ca2"-linked stimulations was markedly decreased at all concentrations examined compared with the controls (Fig. 6, A  and B) ; this attenuation was observed by 24 h of NE infusion, suggesting that the heterologous desensitization develops very rapidly by infusion ofNE, in contrast to the situation in PHEO rats. In these rats, phosphorylase activations by Bt2cAMP and forskolin were not significantly different from those of controls; however, phosphorylase activation by glucagon was significantly (P < 0.05) lower than in control rats (Fig. 6 C) . We further examined the role ofthe alpha, receptors in the rapid development of the reduction in [Ca2+]c response to alpha1-adrenergic stimulation observed in hepatocytes from NE-infused rats for 1-2 d. Saturation binding experiments performed with hepatocytes membrane preparations from rats with NE infusion (1-2 d) showed that the number of hepatic alpha,-adrenergic receptors was slightly decreased, but the observed decrease from control was not significant at the 5% level (98.3±10.6 fmol/mg protein, n = 5 in control rats vs. 79.5±9.6 fmol/mg protein, n = 5 in NE-infused rats), nor were the affinities of the alpha1-adrenergic receptors for [3H]prazosin in hepatic membranes different between control rats and rats with NE infusion (Kd = 0.17±0.05 nM, n = 5 in control rats vs. Kd = 0.13±0.02 nM, n = 5 in NE-treated rats).
Discussion
Using the glycogenolysis in the rat liver as a model system, we have examined in vivo desensitization of the Ca2+ messenger system. In both PHEO-harboring and chronically NE-infused rats, we found two different patterns of desensitization in the ability of Ca2+-mobilizing hormones to activate hepatic phosphorylase. In homologous desensitization for alpha1-adrener- Body weight (g) 295±4 (n = 10) 269±6* (n = 9) 226+5** (n = 9) Plasma dopamine (pg/ml)
Plasma NE (pg/ml) 172±34 (n = 8) 5,530±2,010* (n = 7) 9,200±3,400* (n = 8) Plasma epinephrine (pg/ml) 119±30 (n = 8) 168±46 (n = 7) 128±65 (n = 8) * P < 0.01 vs. age-matched control NEDH rats; tP < 0.05 vs. NE-infused (1-2 d) rats; no symbol indicates no significant difference (P > 0.05).
Plasma catecholamine measurements were done as described in Methods. Values are mean±SEM; n refers to the number of rats. (13, 14) . In one study, attenuation of agonist-promoted phosphorylase activity was observed to be paralleled by a decreased ability of the hormones to stimulate hydrolysis of inositol phospholipids, suggesting that the desensitization of glycogen phosphorylase activation involves unknown events that couple PI breakdown to intracellular Ca2+ mobilization (14) . As The data indicate a near total loss of phosphorylase activation to all Ca2+-linked stimulation after NE infusion or prolonged exposure to pheochromocytoma. Even in these tolerant hepatocytes cAMP-dependent phosphorylase activation by forskolin and Bt2cAMP remains relatively unaffected, suggesting the defect is confined to Ca2+-mobilizing pathway. However, the ability of glucagon in stimulating phosphorylase was found to be significantly decreased in these cells. These results indicate the site of the lesion for the reduced glucagon-stimulated response may lie at the level proximal to cAMP generation. Similar observations were also made in vitro (42) , suggesting that specific desensitization of glucagon-stimulated adenylate cyclase can be elicited by hormones that stimulate the breakdown of inositol phospholipids and Ca2" mobilization. Another important consideration with respect to the attenuated glucagon-stimulated phosphorylase activation in the tolerant hepatocytes is the possible existence of glucagon-stimulated PI turnover/Ca2+ mobilization pathway. The phosphorylase activation by glucagon is now suggested to be mediated by two distinct population of receptors, each couples with different second-messenger systems; one set is linked to stimulate PI turnover/Ca2" mobilization pathway (GRl receptors), and the other set being presumed to account for the stimulation of adenylate cyclase activity (GR2 receptors) (43) . Consequently, it is possible that not only glucagon GR2 receptor-stimulated cAMP production system but also GRl receptor-mediated PI/Ca2+ mobilization pathway itself is undergoing desensitization in these cells. These possibilities are now under investigation.
Desensitization was found in the ability ofCa2+-mobilizing hormones to activate hepatic phosphorylase in both rats harboring PHEO and NE-infused rats. However, the picture and time course of desensitization was markedly different between these two models. The explanation for the differences between two animal models is unclear. Possible factors that could relate to this disparity involve the different NE delivery rate by the tumor from that by osmotic minipump; thus, plasma NE in the PHEO rats was reported to rise gradually to maximum levels by 4 wk after tumor transplantation (44) , whereas plasma NE levels were elevated -30-fold by 14 h, the earliest time tested, and remained at this level for all 7 d in the rats implanted with osmotic minipumps. Also, the potentially important role of the markedly elevated dopamine concentration in the tumor-bearing rats should be considered. Dopamine has been known to be a partial agonist at alpha-adrenergic receptors (45) . Partial agonists may antagonize the effects of the endogenous full agonist, NE. Moreover, recent studies have revealed that PHEO may produce and secrete various neuropeptide-like substances besides catecholamines (46) . Thus, this multisecretory nature of this amine-precursor uptake decarboxylation tumor could contribute the disparity observed.
Whatever the explanation, the current results emphasize that one must be careful in extrapolating findings obtained for desensitization of adrenergic receptor functions in the PHEO model to other settings. The similar observation that increases in catecholamines by implantation of PHEO or infusion of agonists produce somewhat different patterns of regulation of adrenergic receptors has been documented previously in rat renal cortex (47) .
In conclusion, our results indicate the complexity and diversity of mechanisms that may mediate desensitization to excessive in vivo stimulation of Ca2+-messenger system. Not only may desensitization occur through functional uncoupling and downregulation of receptors but also postreceptor mechanism(s), including distal to [Ca2+]c mobilization may be involved in certain cells. Hepatocytes may be a useful model system to pursue further these more poorly understood possibilities.
